Gain Therapeutics stockholders elect eight directors, ratify Ernst & Young as auditor at annual meeting

Gain Therapeutics, Inc.

All eight director nominees elected; broker non-votes of 5,183,098 shares on each nominee.
Vote totals for directors ranged from 4,308,578 (Hasler) to 6,581,651 (Richman).
Ernst & Young AG ratified as independent auditor for FY2024: 11,836,784 for, 119,833 against, 35,623 abstain.
Meeting held June 24, 2024 with quorum present.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.